Home›Stock Screener›Vaxtex Cotfab›Financial Statements

Vaxtex Cotfab Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Vaxtex Cotfab (VCL) reported revenue ₹11 Cr, net profit ₹5 Cr and EPS ₹0.30, with a net profit margin of 45.5% and ROE of 22.7%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review VCL PE ratio trends to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 45.45% 2026 data
EBITDA Margin 18.18% 2026 data
Operating Margin 17.00% 2026 data
Return on Assets 13.51% 2026 data
Return on Equity 22.73% 2026 data

Balance Sheet Ratios

Current Ratio 18.00 2026 data
Equity Ratio 59.46% 2026 data
Asset Turnover 0.30 2026 data

VCL Revenue, Net Profit & EBITDA — Year-on-Year Growth

VCL YoY (March 2025 vs March 2026) — revenue +83.3%, net profit +400.0%, EBITDA +100.0%, expenses +50.0%. Explore VCL true value to estimate fundamental worth using multiple valuation models.

Revenue Growth
+83.3%
Year-over-Year
Net Profit Growth
+400.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
+50.0%
Year-over-Year
Assets Growth
-24.5%
Year-over-Year
Equity Growth
+22.2%
Year-over-Year
Operating Cash Flow Growth
+102.1%
Year-over-Year
Investing Cash Flow Growth
-103.3%
Year-over-Year
Financing Cash Flow Growth
-105.6%
Year-over-Year

VCL Income Statement — Revenue, EBITDA & Net Profit

Vaxtex Cotfab revenue ₹11 Cr, EBITDA ₹2 Cr, net profit ₹5 Cr, EPS ₹0.30 (2026) — net profit margin 45.5%. For live price, earnings ratios and company overview, see Vaxtex Cotfab share price today.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016
Revenue 11 6 17 77 62 26 28 22 18 5 1
Expenses 9 6 26 76 59 25 26 21 18 4 1
EBITDA 2 1 -9 1 3 2 1 1 0 0 0
Operating Profit Margin % 17.00% -10.00% -54.00% -1.00% 5.00% 5.00% 5.00% 4.00% 2.00% -2.00% -3.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 1 1 1 1 0 0 0 0
Profit Before Tax 5 0 -9 1 2 0 0 1 0 0 0
Tax 0 -1 0 0 1 0 0 0 0 0 0
Net Profit 5 1 -9 1 2 0 0 1 0 0 0
Earnings Per Share (₹) 0.30 0.05 -0.56 0.11 0.15 0.30 0.15 14.96 4.24 0.46 0.19

VCL Balance Sheet — Assets, Liabilities & Shareholders' Equity

VCL total assets ₹37 Cr, total equity ₹22 Cr, total liabilities ₹ Cr (2026) — ROE 22.7%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
ASSETS
Total Assets 37 49 49 70 24 22 28 14 10 5 4
Current Assets 36 41 42 66 20 18 17 7 9 4 4
Fixed Assets 0 1 1 4 4 4 2 2 2 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 7 8 7 1 1 0 0 0 0 0 0
Other Assets 0 40 41 65 19 18 26 12 8 4 4
LIABILITIES
Total Liabilities
Current Liabilities 2 7 10 5 6 10 9 3 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 22 18 19 24 10 9 9 5 4 4 4
Share Capital 18 18 18 13 10 6 6 0 0 0 0
Reserves & Surplus 4 0 0 11 0 3 3 4 4 4 4

VCL Cash Flow Statement — Operating, Investing & Financing

Vaxtex Cotfab operating cash flow ₹1 Cr, investing ₹-1 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 1 -48 -11 7 1 -7 2 2 -3 0 0
Investing Activities -1 30 0 -4 2 -5 -5 -1 3 0 0
Financing Activities -1 18 11 -3 -3 12 3 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0 0